CoChat

Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes

Clarke, Christine L., Graham, J. Dinny · 2012 · PLoS ONE
Cited by 74

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The transcriptional effects of the ovarian hormone progesterone are pleiotropic, and binding to DNA of the nuclear progesterone receptor (PR), a ligand-activated transcription factor, results in diverse outcomes in a range of target tissues. To determine whether distinct patterns of genomic interaction of PR contribute to the cell specificity of the PR transcriptome, we have compared the genomic binding sites for PR in breast cancer cells and immortalized normal breast cells. PR binding was correlated with transcriptional outcome in both cell lines, with 60% of progestin-regulated genes associated with one or more PR binding regions. There was a remarkably low overlap between the PR cistromes of the two cell lines, and a similarly low overlap in transcriptional targets. A conserved PR binding element was identified in PR binding regions from both cell lines, but there were distinct patterns of enrichment of known cofactor binding motifs, with FOXA1 sites over-represented in breast cancer cell binding regions and NF1 and AP-1 motifs uniquely enriched in the immortalized normal line. Downstream analyses suggested that differential cofactor availability may generate these distinct PR cistromes, indicating that cofactor levels may modulate PR specificity. Taken together these data suggest that cell-specificity of PR binding is determined by the coordinated effects of key binding cofactors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035859

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 56

  1. BA Lieberman, 1993, The constitution of a progesterone response element., Mol Endocrinol, 7, 515
  2. CC Nelson, 1999, Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements., Mol Endocrinol, 13, 2090, 10.1210/mend.13.12.0396 · doi:10.1210/mend.13.12.0396 · Paper page
  3. SA Onate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily., Science, 270, 1354, 10.1126/science.270.5240.1354 · DOI · Paper page
  4. Z Liu, 2001, Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin., Proc Natl Acad Sci U S A, 98, 12426, 10.1073/pnas.231474798 · DOI · Paper page
  5. KM Scarpin, 2009, Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression., Nucl Recept Signal, 7, e009, 10.1621/nrs.07009 · DOI · Paper page
  6. GP Vicent, 2006, Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways., Ann N Y Acad Sci, 1089, 59, 10.1196/annals.1386.025 · DOI
  7. GP Vicent, 2010, Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin., Mol Endocrinol, 24, 2088, 10.1210/me.2010-0027 · DOI · Paper page
  8. GP Vicent, 2010, Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements., J Biol Chem, 285, 2622, 10.1074/jbc.M109.060848 · DOI
  9. JR Friedman, 2006, The Foxa family of transcription factors in development and metabolism., Cell Mol Life Sci, 63, 2317, 10.1007/s00018-006-6095-6 · DOI · Paper page
  10. GM Bernardo, 2010, FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis., Development, 137, 2045, 10.1242/dev.043299 · DOI · Paper page
  11. JS Carroll, 2006, Genome-wide analysis of estrogen receptor binding sites., Nat Genet, 38, 1289, 10.1038/ng1901 · DOI · Paper page
  12. Q Wang, 2007, A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth., Mol Cell, 27, 380, 10.1016/j.molcel.2007.05.041 · DOI · Paper page
  13. L Cicatiello, 2004, Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter., Mol Cell Biol, 24, 7260, 10.1128/MCB.24.16.7260-7274.2004 · DOI · Paper page
  14. PJ Kushner, 2000, Estrogen receptor pathways to AP-1., J Steroid Biochem Mol Biol, 74, 311, 10.1016/S0960-0760(00)00108-4 · DOI · Paper page
  15. L Tseng, 2003, Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts., DNA Cell Biol, 22, 633, 10.1089/104454903770238102 · DOI
  16. W Beguelin, 2010, Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3., Mol Cell Biol, 30, 5456, 10.1128/MCB.00012-10 · DOI · Paper page
  17. EJ Faivre, 2008, Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors., Mol Endocrinol, 22, 823, 10.1210/me.2007-0437 · DOI · Paper page
  18. JD Graham, 1997, Physiological action of progesterone in target tissues., Endocr Rev, 18, 502
  19. TA Longacre, 1986, A correlative morphologic study of human breast and endometrium in the menstrual cycle., Am J Surg Pathol, 10, 382, 10.1097/00000478-198606000-00003 · DOI · Paper page
  20. CI Ace, 2004, Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase., Reprod Biol Endocrinol, 2, 54, 10.1186/1477-7827-2-54 · DOI · Paper page
  21. JM Borthwick, 2003, Determination of the transcript profile of human endometrium., Mol Hum Reprod, 9, 19, 10.1093/molehr/gag004 · DOI · Paper page
  22. JD Graham, 2005, Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells., Mol Endocrinol, 19, 2713, 10.1210/me.2005-0126 · DOI
  23. JK Richer, 2002, Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells., J Biol Chem, 277, 5209, 10.1074/jbc.M110090200 · DOI · Paper page
  24. V Beral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study., Lancet, 362, 419, 10.1016/S0140-6736(03)14596-5 · DOI · Paper page
  25. V Beral, 2011, Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy., J Natl Cancer Inst, 103, 296, 10.1093/jnci/djq527 · DOI · Paper page
  26. JE Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial., JAMA, 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page
  27. RT Chlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women., JAMA, 304, 1684, 10.1001/jama.2010.1500 · DOI · Paper page
  28. JD Graham, 2009, DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast., Endocrinology, 150, 3318, 10.1210/en.2008-1630 · DOI
  29. B Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome., Genome Biol, 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
  30. A Mortazavi, 2008, Mapping and quantifying mammalian transcriptomes by RNA-Seq., Nat Methods, 5, 621, 10.1038/nmeth.1226 · DOI · Paper page
  31. AV Roschke, 2003, Karyotypic complexity of the NCI-60 drug-screening panel., Cancer Res, 63, 8634
  32. Q Tang, 2011, A comprehensive view of nuclear receptor cancer cistromes., Cancer Res, 71, 6940, 10.1158/0008-5472.CAN-11-2091 · DOI · Paper page
  33. D Wang, 2011, Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA., Nature, 474, 390, 10.1038/nature10006 · DOI · Paper page
  34. R Joseph, 2010, Integrative model of genomic factors for determining binding site selection by estrogen receptor-alpha., Mol Syst Biol, 6, 456, 10.1038/msb.2010.109 · DOI · Paper page
  35. R Bravieri, 1997, Different DNA contact schemes are used by two winged helix proteins to recognize a DNA binding sequence., Nucleic Acids Res, 25, 2888, 10.1093/nar/25.14.2888 · DOI
  36. LA Cirillo, 2007, Specific interactions of the wing domains of FOXA1 transcription factor with DNA., J Mol Biol, 366, 720, 10.1016/j.jmb.2006.11.087 · DOI
  37. S Pierrou, 1994, Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending., EMBO J, 13, 5002, 10.1002/j.1460-2075.1994.tb06827.x · DOI · Paper page
  38. WJ Welboren, 2009, ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands., EMBO J, 28, 1418, 10.1038/emboj.2009.88 · DOI · Paper page
  39. KL Macquarrie, 2011, Genome-wide transcription factor binding: beyond direct target regulation., Trends Genetics, 27, 141, 10.1016/j.tig.2011.01.001 · DOI · Paper page
  40. SA Krum, 2008, Unique ERalpha cistromes control cell type-specific gene regulation., Molecular Endocrinology, 22, 2393, 10.1210/me.2008-0100 · DOI · Paper page
  41. AY So, 2007, Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor., PLoS Genet, 3, e94, 10.1371/journal.pgen.0030094 · DOI · Paper page
  42. EC Bolton, 2007, Cell- and gene-specific regulation of primary target genes by the androgen receptor., Genes Dev, 21, 2005, 10.1101/gad.1564207 · DOI · Paper page
  43. P Yin, 2012, Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells., PLoS One, 7, e29021, 10.1371/journal.pone.0029021 · DOI · Paper page
  44. GV Rayasam, 2005, Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro., Mol Cell Biol, 25, 2406, 10.1128/MCB.25.6.2406-2418.2005 · DOI · Paper page
  45. S Belikov, 2009, FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter., Mol Cell Biol, 29, 5413, 10.1128/MCB.00368-09 · DOI · Paper page
  46. I Garcia-Bassets, 2007, Histone methylation-dpendent mechanisms impose ligand dependency for gene activation by nuclear receptors., Cell, 128, 505, 10.1016/j.cell.2006.12.038 · DOI · Paper page
  47. E Metzger, 2005, LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription., Nature, 437, 436, 10.1038/nature04020 · DOI · Paper page
  48. J Murtagh, 2003, The Nuclear Factor I (NFI) gene family in mammary gland development and function., J Mammary Gland Biol Neoplasia, 8, 241, 10.1023/A:1025909109843 · DOI
  49. CH Streuli, 1995, Stat5 as a target for regulation by extracellular matrix., J Biol Chem, 270, 21639, 10.1074/jbc.270.37.21639 · DOI · Paper page
  50. CL Clarke, 1987, Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques., Endocrinology, 121, 1123, 10.1210/endo-121-3-1123 · DOI · Paper page
  51. H Ji, 2008, An integrated software system for analyzing ChIP-chip and ChIP-seq data., Nat Biotechnol, 26, 1293, 10.1038/nbt.1505 · DOI · Paper page
  52. S Heinz, 2010, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities., Mol Cell, 38, 576, 10.1016/j.molcel.2010.05.004 · DOI · Paper page
  53. TL Bailey, 2006, MEME: discovering and analyzing DNA and protein sequence motifs., Nucleic Acids Res, 34, W369, 10.1093/nar/gkl198 · DOI · Paper page
  54. TL Bailey, 2010, The value of position-specific priors in motif discovery using MEME., BMC Bioinformatics, 11, 179, 10.1186/1471-2105-11-179 · DOI
  55. M Reich, 2006, GenePattern 2.0., Nat Genet, 38, 500, 10.1038/ng0506-500 · DOI · Paper page
  56. JD Graham, 1995, Characterization of progesterone receptor A and B expression in human breast cancer., Cancer Res, 55, 5063

Cited by

Metadata

Authors
Clarke, C. L., & Graham, J. D.
Venue
PLoS ONE
Published
2012-04-24
Volume
7
Issue
4
Pages
e35859
ISSN
1932-6203
Cited by
74
References
9
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.